Refanezumab
Refanezumab (GSK249320) is a monoclonal antibody designed for the recovery of motor function after stroke.
Snapshot
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Refanezumab (GSK249320) is a monoclonal antibody designed for the recovery of motor function after stroke. This drug was developed by GlaxoSmithKline.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1177181628 under CC BY-SA 4.0; modifications have been made.